GABAA receptor subtype changes in the substantia nigra of the rat following quinolinate lesions in the striatum: A correlative in situ hybridization and immunohistochemical study

Neuroscience

Volumn 74, Issue 1, 1996, Pages 89-98

  Nicholson, L F B ^a   Waldvogel, H J ^a   Faull, R L M ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

GABAA receptor; Quinolinate lesion; Rat; Substantia nigra

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; QUINOLINIC ACID; MESSENGER RNA; RECEPTOR SUBTYPE;

ANIMAL; ARTICLE; CORPUS STRIATUM; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; METABOLISM; RAT; SUBSTANTIA NIGRA; WISTAR RAT; ANIMAL TISSUE; AUTORADIOGRAPHY; BRAIN INJURY; DEGENERATIVE DISEASE; GENE EXPRESSION; HUNTINGTON CHOREA; IMAGE ANALYSIS; MICROSCOPY; NERVE CELL DEGENERATION; NONHUMAN; OLIGONUCLEOTIDE PROBE; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

ANIMALS; CORPUS STRIATUM; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; QUINOLINIC ACID; RATS; RATS, WISTAR; RECEPTORS, GABA-A; SUBSTANTIA NIGRA;

EID: 0029657986     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(96)00080-2     Document Type: Article

References (18)

1. 4 subunits mRNAs in the rat brain. Molec. Brain Res. 12, 293-314.
2. Beal M. F., Ferrante R. J., Swartz K. J. and Kowall N. W. (1991) Chronic quinolinic acid lesions in rats closely resemble Huntington's disease. J. Neurosci. 11, 1649-1659.
3. Beal M. F., Kowall N. W., Ellison D. W., Mazurek M. F., Swartz K. J. and Martin J. B. (1986) Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 321, 168-171.
4. Beal M. F., Kowall N. W., Swartz K. J., Ferrante R. J. and Martin J. B. (1989) Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions. Synapse 3, 38-47.
5. Boegman R. J., Smith Y. and Parent A. (1987) Quinolinic acid does not spare striatal neuropeptide Y-immunoreactive neurons. Brain Res. 415, 178-182.
6. Corda M. G., Concas A., Porceddu M. L., Sanna E. and Biggio G. (1986) Striatonigral denervation increases type II benzodiazepine receptors in the substantia nigra of the rat. Neuropharmacology 25, 59-62.
7. Davies S. W. and Roberts P. J. (1987) No evidence for preservation of somatostatin-containing neurons after intrastriatal injections of quinolinic acid. Nature 327, 326-329.
8. DiFiglia M. (1990) Excitotoxic injury of the neostriatum: a model for Huntington's disease. Trends Neurosci. 13, 286-289.
9. Ellison D. W., Beal M. F., Mazurek M. F., Malloy J. R., Bird E. D. and Martin J. B. (1987) Amino acid neurotransmitter abnormalities in Huntington's disease and the quinolinic acid animal model of Huntington's disease. Brain 110, 1657-1673.
10. Faull R. L. M. and Carman J. B. (1968) Ascending projections of the substantia nigra in the rat. J. comp. Neurol. 132, 73-92.
11. Faull R. L. M. and Villiger J. W. (1988) Multiple benzodiazepine receptors in the human basal ganglia: a detailed pharmacological and anatomical study. Neuroscience 24, 433-451.
12. Faull R. L. M., Villiger J. W. and Holford N. H. G. (1987) Benzodiazepine receptors in the human cerebellar cortex: a quantitative autoradiographic and pharmacological study demonstrating the predominance of type I receptors. Brain Res. 411, 379-385.
13. A-benzodiazepine receptors in the basal ganglia in Huntington's disease and in the quinolinic acid-lesioned rat. In Progress in Brain Research (eds Arbuthnott G. W. and Emson P. C.), Vol. 99, pp.105-123. Elsevier Science, Amsterdam.
14. A receptor changes in the basal ganglia in Huntington's disease in the human brain and in the quinolinic acid lesioned rat model of the disease following fetal neuron transplants. In Neurotransmitters in the Human Brain 1 (eds Tracey D. J. et al.), pp. 173-197. Plenum Press, New York.
15. A-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J. comp. Neurol. 359, 154-194.
16. Häring P., Stähli C., Schoch P., Takács B., Staehelin T. and Möhler H. (1985) Monoclonal antibodies reveal structural homogeneity of γ-aminobutyric acid/benzodiazepine receptors in different brain areas. Proc. natn. Acad. Sci. U.S.A. 82, 4837-4841.
17. A receptors in the human hippocampal formation. J. Neurosci. 8, 1370-1383.
18. A receptors. Neuron 3, 745-753.